PASK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P46937 | T114 | Sugiyama | YAP1 YAP65 | sFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQL |
| P52747 | T352 | Sugiyama | ZNF143 SBF STAF | EGCGRSFTTSNIRKVHVRTHtGERPYyCTEPGCGRAFASAT |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P61964 | S49 | PSP | WDR5 BIG3 | tPVKPNYALKFTLAGHTKAVsSVKFSPNGEWLASSSADKLI |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62753 | S235 | EPSD | RPS6 OK/SW-cl.2 | KRMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK______ |
| P62753 | S236 | EPSD | RPS6 OK/SW-cl.2 | RMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK_______ |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68104 | T432 | EPSD|PSP | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q92597 | T366 | Sugiyama | NDRG1 CAP43 DRG1 RTP | tSEGTRsRsHtsEGtRsRsHtsEGAHLDItPNsGAAGNsAG |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q96RG2 | S1273 | Sugiyama | PASK KIAA0135 | QPVNLADYTWEEVFRVNKPEsGVLsAAsLEMGNRsLsDVAQ |
| Q96RG2 | S1277 | Sugiyama | PASK KIAA0135 | LADYTWEEVFRVNKPEsGVLsAAsLEMGNRsLsDVAQAQEL |
| Q96RG2 | S1280 | Sugiyama | PASK KIAA0135 | YTWEEVFRVNKPEsGVLsAAsLEMGNRsLsDVAQAQELCGG |
| Q96RG2 | S996 | Sugiyama | PASK KIAA0135 | FEEPPKAVELEGLAACEGEYsQKYSTMSPLGSGAFGFVWTA |
| Q96RG2 | T1161 | ELM|iPTMNet|EPSD|PSP | PASK KIAA0135 | TIKLIDFGSAAYLERGKLFYtFCGtIEYCAPEVLMGNPYRG |
| Q96RG2 | T1165 | ELM|iPTMNet|EPSD|PSP | PASK KIAA0135 | IDFGSAAYLERGKLFYtFCGtIEYCAPEVLMGNPYRGPELE |
| Q96RG2 | T307 | PSP | PASK KIAA0135 | GQHIPKNLKIQRSVGRARDGtTFPLSLKLKSQPSSEEATTG |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.000008 | 5.087 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.000010 | 4.993 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.000024 | 4.625 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.000033 | 4.482 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.000039 | 4.405 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.000053 | 4.277 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.000049 | 4.307 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.000055 | 4.262 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.000052 | 4.284 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.000124 | 3.907 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.000148 | 3.829 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.000150 | 3.824 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.000172 | 3.765 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.000206 | 3.686 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.000206 | 3.686 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.000206 | 3.686 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.000224 | 3.651 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.000246 | 3.609 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.000292 | 3.534 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.000345 | 3.462 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.000406 | 3.392 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.000475 | 3.324 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.000475 | 3.323 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.000501 | 3.300 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.000641 | 3.193 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.000694 | 3.159 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.000813 | 3.090 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.000851 | 3.070 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.000975 | 3.011 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.001032 | 2.986 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 0.001082 | 2.966 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.001132 | 2.946 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.001113 | 2.954 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.001234 | 2.909 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.001204 | 2.919 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.001324 | 2.878 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.001435 | 2.843 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.001491 | 2.827 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.001579 | 2.802 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.002054 | 2.687 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 0.002190 | 2.659 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 0.002190 | 2.659 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 0.002190 | 2.659 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.002262 | 2.645 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.002301 | 2.638 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.002301 | 2.638 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.002453 | 2.610 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.002453 | 2.610 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.002419 | 2.616 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.002419 | 2.616 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.002571 | 2.590 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.002683 | 2.571 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.002851 | 2.545 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.002986 | 2.525 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.003091 | 2.510 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.003556 | 2.449 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.004045 | 2.393 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.004313 | 2.365 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.004422 | 2.354 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.004751 | 2.323 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.004881 | 2.311 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.004881 | 2.311 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.005073 | 2.295 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.005384 | 2.269 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.005846 | 2.233 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.006600 | 2.180 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.006600 | 2.180 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.006600 | 2.180 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.006412 | 2.193 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.007010 | 2.154 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.007466 | 2.127 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.008092 | 2.092 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.008895 | 2.051 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.008829 | 2.054 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.008895 | 2.051 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.008966 | 2.047 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.009264 | 2.033 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.009438 | 2.025 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.009481 | 2.023 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.009533 | 2.021 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.010561 | 1.976 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.010561 | 1.976 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.009976 | 2.001 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.010371 | 1.984 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.011196 | 1.951 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.011351 | 1.945 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.011458 | 1.941 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 0.012565 | 1.901 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.012388 | 1.907 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.012454 | 1.905 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 0.012441 | 1.905 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.013069 | 1.884 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.013152 | 1.881 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.013152 | 1.881 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.013501 | 1.870 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.013501 | 1.870 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.014574 | 1.836 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.015159 | 1.819 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.015159 | 1.819 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.013968 | 1.855 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 0.014510 | 1.838 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.014690 | 1.833 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.015357 | 1.814 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.015357 | 1.814 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.015357 | 1.814 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.015519 | 1.809 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.016783 | 1.775 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.017974 | 1.745 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.016839 | 1.774 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.016948 | 1.771 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.017974 | 1.745 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.016840 | 1.774 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 0.016783 | 1.775 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.018416 | 1.735 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.018416 | 1.735 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.018871 | 1.724 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.019267 | 1.715 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.019267 | 1.715 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.020382 | 1.691 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.021968 | 1.658 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.023746 | 1.624 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.022598 | 1.646 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.024067 | 1.619 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.021867 | 1.660 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.022819 | 1.642 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.024109 | 1.618 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.025673 | 1.591 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 0.026766 | 1.572 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 0.026766 | 1.572 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.027426 | 1.562 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.027821 | 1.556 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.027821 | 1.556 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.027821 | 1.556 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.027821 | 1.556 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.028031 | 1.552 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.029987 | 1.523 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.029987 | 1.523 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.030294 | 1.519 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 0.030596 | 1.514 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.034455 | 1.463 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.033449 | 1.476 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.030596 | 1.514 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.034235 | 1.466 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.034744 | 1.459 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.034757 | 1.459 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.035452 | 1.450 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 0.035608 | 1.448 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.035608 | 1.448 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.035608 | 1.448 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.035608 | 1.448 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.035608 | 1.448 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.036372 | 1.439 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.036827 | 1.434 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.036883 | 1.433 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 0.041053 | 1.387 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 0.041053 | 1.387 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.045066 | 1.346 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.045066 | 1.346 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.038822 | 1.411 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.045066 | 1.346 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.039478 | 1.404 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.040778 | 1.390 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.044368 | 1.353 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 0.045066 | 1.346 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 0.045066 | 1.346 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.046160 | 1.336 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.046160 | 1.336 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.046417 | 1.333 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 0.046810 | 1.330 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.047147 | 1.327 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.047161 | 1.326 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.047161 | 1.326 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.047165 | 1.326 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.048527 | 1.314 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.049556 | 1.305 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.049929 | 1.302 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.050797 | 1.294 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.055515 | 1.256 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 0.052985 | 1.276 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.059530 | 1.225 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.056415 | 1.249 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.056415 | 1.249 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.061381 | 1.212 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.054210 | 1.266 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.061335 | 1.212 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.051742 | 1.286 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.059530 | 1.225 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.061426 | 1.212 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.051620 | 1.287 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.056415 | 1.249 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.053486 | 1.272 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.052985 | 1.276 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.054989 | 1.260 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.061843 | 1.209 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.062373 | 1.205 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.064978 | 1.187 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.064978 | 1.187 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.065670 | 1.183 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.066570 | 1.177 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.066603 | 1.177 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 0.066717 | 1.176 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.066717 | 1.176 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.066717 | 1.176 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.066717 | 1.176 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.066717 | 1.176 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.068533 | 1.164 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.068984 | 1.161 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.069489 | 1.158 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.080422 | 1.095 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 0.080422 | 1.095 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.080422 | 1.095 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.080422 | 1.095 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 0.080422 | 1.095 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.080422 | 1.095 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 0.080422 | 1.095 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.080422 | 1.095 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 0.080422 | 1.095 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 0.080422 | 1.095 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.078590 | 1.105 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 0.078590 | 1.105 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.078590 | 1.105 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.088837 | 1.051 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 0.081275 | 1.090 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.080692 | 1.093 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.083446 | 1.079 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.074534 | 1.128 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.081089 | 1.091 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.073688 | 1.133 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.082607 | 1.083 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.083446 | 1.079 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.089039 | 1.050 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.079298 | 1.101 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.088140 | 1.055 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.078590 | 1.105 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 0.078590 | 1.105 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.089039 | 1.050 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.078045 | 1.108 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.089185 | 1.050 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.089494 | 1.048 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 0.091062 | 1.041 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.091062 | 1.041 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 0.091062 | 1.041 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.093738 | 1.028 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.094490 | 1.025 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.094490 | 1.025 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.095747 | 1.019 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.097403 | 1.011 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.097540 | 1.011 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.099045 | 1.004 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.103304 | 0.986 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.104032 | 0.983 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.104064 | 0.983 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.104064 | 0.983 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 0.104064 | 0.983 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 0.104064 | 0.983 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.104064 | 0.983 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.104894 | 0.979 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.105915 | 0.975 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.108208 | 0.966 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.110469 | 0.957 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.112995 | 0.947 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.114284 | 0.942 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.114555 | 0.941 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.114706 | 0.940 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.115681 | 0.937 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 0.118178 | 0.927 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 0.118178 | 0.927 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 0.118178 | 0.927 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 0.118178 | 0.927 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 0.154385 | 0.811 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 0.154385 | 0.811 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 0.154385 | 0.811 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 0.154385 | 0.811 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 0.154385 | 0.811 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 0.154385 | 0.811 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 0.154385 | 0.811 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.131403 | 0.881 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.133066 | 0.876 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.134145 | 0.872 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.139130 | 0.857 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.126226 | 0.899 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.137259 | 0.862 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.131403 | 0.881 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 0.145625 | 0.837 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.123654 | 0.908 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.152363 | 0.817 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 0.123761 | 0.907 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 0.117531 | 0.930 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.140393 | 0.853 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.137026 | 0.863 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 0.142605 | 0.846 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.154385 | 0.811 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.133692 | 0.874 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.125207 | 0.902 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.118178 | 0.927 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.129894 | 0.886 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.142605 | 0.846 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.140393 | 0.853 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 0.117531 | 0.930 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.129894 | 0.886 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.117537 | 0.930 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.140000 | 0.854 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 0.189108 | 0.723 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 0.222408 | 0.653 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.222408 | 0.653 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 0.222408 | 0.653 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.222408 | 0.653 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.254341 | 0.595 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 0.254341 | 0.595 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 0.284966 | 0.545 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 0.284966 | 0.545 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 0.284966 | 0.545 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.174911 | 0.757 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 0.174911 | 0.757 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 0.174911 | 0.757 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 0.314334 | 0.503 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 0.314334 | 0.503 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 0.314334 | 0.503 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 0.314334 | 0.503 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 0.314334 | 0.503 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 0.189884 | 0.722 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 0.205019 | 0.688 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 0.342498 | 0.465 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.342498 | 0.465 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 0.342498 | 0.465 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 0.342498 | 0.465 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 0.342498 | 0.465 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 0.342498 | 0.465 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.220278 | 0.657 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.220278 | 0.657 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.220278 | 0.657 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 0.235626 | 0.628 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 0.369506 | 0.432 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 0.369506 | 0.432 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.251030 | 0.600 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 0.182801 | 0.738 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 0.266459 | 0.574 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.266459 | 0.574 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 0.281885 | 0.550 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.281885 | 0.550 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.281885 | 0.550 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.281885 | 0.550 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.281885 | 0.550 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 0.420245 | 0.376 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 0.420245 | 0.376 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 0.420245 | 0.376 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.193036 | 0.714 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.193036 | 0.714 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.159869 | 0.796 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.247606 | 0.606 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.247606 | 0.606 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.166594 | 0.778 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 0.327900 | 0.484 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.444064 | 0.353 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.444064 | 0.353 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.444064 | 0.353 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.444064 | 0.353 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.180368 | 0.744 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.180368 | 0.744 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.227612 | 0.643 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 0.343078 | 0.465 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 0.343078 | 0.465 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.201782 | 0.695 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.245453 | 0.610 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.358145 | 0.446 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.358145 | 0.446 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 0.466906 | 0.331 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.466906 | 0.331 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.466906 | 0.331 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.254488 | 0.594 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.254488 | 0.594 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.373083 | 0.428 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.272750 | 0.564 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.281965 | 0.550 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.387879 | 0.411 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.224821 | 0.648 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.254667 | 0.594 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.270373 | 0.568 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.431281 | 0.365 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.431281 | 0.365 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.383179 | 0.417 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.383179 | 0.417 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.394392 | 0.404 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.445384 | 0.351 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.405550 | 0.392 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.403753 | 0.394 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.413077 | 0.384 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.460290 | 0.337 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.445384 | 0.351 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.394402 | 0.404 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.192358 | 0.716 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.445384 | 0.351 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.231561 | 0.635 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.459290 | 0.338 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.281965 | 0.550 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.160143 | 0.795 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.193286 | 0.714 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.251030 | 0.600 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.281885 | 0.550 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 0.444064 | 0.353 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.444064 | 0.353 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 0.201524 | 0.696 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.239197 | 0.621 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.239197 | 0.621 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.269967 | 0.569 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.318564 | 0.497 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.269967 | 0.569 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 0.222408 | 0.653 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 0.254341 | 0.595 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 0.254341 | 0.595 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 0.284966 | 0.545 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 0.369506 | 0.432 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.266459 | 0.574 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.395407 | 0.403 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.402519 | 0.395 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.352469 | 0.453 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.465390 | 0.332 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 0.235626 | 0.628 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.239197 | 0.621 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.208752 | 0.680 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.371921 | 0.430 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.371921 | 0.430 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.279612 | 0.553 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.426547 | 0.370 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.205019 | 0.688 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.235626 | 0.628 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.182801 | 0.738 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.395407 | 0.403 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 0.297282 | 0.527 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 0.466906 | 0.331 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.254488 | 0.594 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 0.373083 | 0.428 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.294299 | 0.531 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.326708 | 0.486 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 0.205019 | 0.688 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.431624 | 0.365 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.318873 | 0.496 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.254341 | 0.595 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 0.284966 | 0.545 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 0.342498 | 0.465 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 0.235626 | 0.628 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.395407 | 0.403 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.231561 | 0.635 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.387879 | 0.411 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.278304 | 0.555 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.192358 | 0.716 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.246900 | 0.607 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.419801 | 0.377 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.326589 | 0.486 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.445384 | 0.351 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.345029 | 0.462 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 0.189108 | 0.723 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 0.189108 | 0.723 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 0.222408 | 0.653 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 0.254341 | 0.595 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 0.284966 | 0.545 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 0.284966 | 0.545 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 0.342498 | 0.465 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 0.369506 | 0.432 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.420245 | 0.376 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.420245 | 0.376 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 0.420245 | 0.376 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.180368 | 0.744 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.466906 | 0.331 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.466906 | 0.331 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.254667 | 0.594 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.402519 | 0.395 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.309861 | 0.509 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.294248 | 0.531 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.338858 | 0.470 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.389343 | 0.410 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.441249 | 0.355 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.345873 | 0.461 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.310445 | 0.508 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.433142 | 0.363 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.315227 | 0.501 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.230460 | 0.637 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.300526 | 0.522 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.337949 | 0.471 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 0.343078 | 0.465 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.381961 | 0.418 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.258754 | 0.587 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.251030 | 0.600 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.281885 | 0.550 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.338005 | 0.471 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.256951 | 0.590 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.337949 | 0.471 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.302355 | 0.519 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 0.342498 | 0.465 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 0.369506 | 0.432 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 0.395407 | 0.403 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 0.395407 | 0.403 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.420245 | 0.376 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.182787 | 0.738 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.402519 | 0.395 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.427675 | 0.369 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.406289 | 0.391 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.420152 | 0.377 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.201782 | 0.695 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.372488 | 0.429 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.167796 | 0.775 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.373083 | 0.428 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.155944 | 0.807 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.465390 | 0.332 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.416990 | 0.380 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.431281 | 0.365 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 0.222408 | 0.653 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 0.284966 | 0.545 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 0.342498 | 0.465 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 0.369506 | 0.432 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 0.369506 | 0.432 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 0.395407 | 0.403 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 0.444064 | 0.353 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 0.466906 | 0.331 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.338005 | 0.471 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.309400 | 0.509 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.388768 | 0.410 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.420103 | 0.377 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.218819 | 0.660 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.218819 | 0.660 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.315098 | 0.502 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.416647 | 0.380 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.343078 | 0.465 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.427675 | 0.369 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.314334 | 0.503 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.227612 | 0.643 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.345029 | 0.462 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.196268 | 0.707 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 0.319223 | 0.496 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.272133 | 0.565 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.384096 | 0.416 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.319223 | 0.496 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 0.254341 | 0.595 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 0.314334 | 0.503 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 0.369506 | 0.432 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 0.420245 | 0.376 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.201524 | 0.696 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 0.444064 | 0.353 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.269967 | 0.569 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.288657 | 0.540 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.347413 | 0.459 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.393415 | 0.405 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.199127 | 0.701 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.373083 | 0.428 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.171796 | 0.765 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.326589 | 0.486 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.358807 | 0.445 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.395407 | 0.403 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 0.303873 | 0.517 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.275761 | 0.559 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.369836 | 0.432 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.185228 | 0.732 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.326589 | 0.486 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.402519 | 0.395 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.284966 | 0.545 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.189884 | 0.722 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 0.342498 | 0.465 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 0.395407 | 0.403 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.173428 | 0.761 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 0.327900 | 0.484 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 0.444064 | 0.353 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.198703 | 0.702 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.246900 | 0.607 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 0.402519 | 0.395 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.189884 | 0.722 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.459290 | 0.338 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.312628 | 0.505 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.427675 | 0.369 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.438630 | 0.358 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.460290 | 0.337 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.281965 | 0.550 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.326589 | 0.486 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.302355 | 0.519 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.352272 | 0.453 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 0.314334 | 0.503 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 0.220278 | 0.657 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 0.395407 | 0.403 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.216510 | 0.665 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.281965 | 0.550 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.358145 | 0.446 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.358145 | 0.446 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.371921 | 0.430 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 0.466906 | 0.331 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.429608 | 0.367 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.342498 | 0.465 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.269967 | 0.569 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.281965 | 0.550 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.402519 | 0.395 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.218211 | 0.661 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.193036 | 0.714 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.246066 | 0.609 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.214677 | 0.668 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 0.444064 | 0.353 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.402519 | 0.395 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.177080 | 0.752 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.327900 | 0.484 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 0.235626 | 0.628 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.395407 | 0.403 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.312628 | 0.505 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.292538 | 0.534 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.298077 | 0.526 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.176415 | 0.753 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.189884 | 0.722 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 0.358145 | 0.446 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.227838 | 0.642 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.327900 | 0.484 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 0.445384 | 0.351 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.440840 | 0.356 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.457936 | 0.339 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 0.269967 | 0.569 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.212245 | 0.673 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.252586 | 0.598 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.460290 | 0.337 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.373083 | 0.428 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.343078 | 0.465 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.468203 | 0.330 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.469645 | 0.328 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.470068 | 0.328 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.470985 | 0.327 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.470985 | 0.327 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.470985 | 0.327 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.472809 | 0.325 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.472990 | 0.325 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.480247 | 0.319 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.481309 | 0.318 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.481583 | 0.317 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.486172 | 0.313 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.486478 | 0.313 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.486478 | 0.313 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.486478 | 0.313 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.486478 | 0.313 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.486478 | 0.313 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.486478 | 0.313 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.486647 | 0.313 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.486647 | 0.313 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.486647 | 0.313 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.488811 | 0.311 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 0.488811 | 0.311 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 0.488811 | 0.311 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.488811 | 0.311 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.488811 | 0.311 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.488811 | 0.311 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.488811 | 0.311 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.488811 | 0.311 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 0.488811 | 0.311 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.488811 | 0.311 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 0.488811 | 0.311 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.488811 | 0.311 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 0.488811 | 0.311 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 0.488811 | 0.311 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 0.488811 | 0.311 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.488811 | 0.311 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 0.488811 | 0.311 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 0.488811 | 0.311 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 0.488811 | 0.311 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.489209 | 0.311 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.492079 | 0.308 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 0.492079 | 0.308 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.498567 | 0.302 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.499679 | 0.301 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.499750 | 0.301 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 0.499750 | 0.301 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 0.499750 | 0.301 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 0.499750 | 0.301 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.499750 | 0.301 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.509817 | 0.293 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.509817 | 0.293 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.509817 | 0.293 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.509817 | 0.293 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.509817 | 0.293 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.512635 | 0.290 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.512693 | 0.290 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.512751 | 0.290 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.512798 | 0.290 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.512798 | 0.290 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.512798 | 0.290 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.512798 | 0.290 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.513109 | 0.290 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.525621 | 0.279 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 0.525621 | 0.279 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.525621 | 0.279 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.525621 | 0.279 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 0.529961 | 0.276 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 0.529961 | 0.276 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.529961 | 0.276 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 0.529961 | 0.276 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 0.529961 | 0.276 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 0.529961 | 0.276 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 0.529961 | 0.276 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.529961 | 0.276 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.532967 | 0.273 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.536929 | 0.270 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.538213 | 0.269 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.538213 | 0.269 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.538485 | 0.269 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.540679 | 0.267 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.542896 | 0.265 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.542896 | 0.265 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.546942 | 0.262 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.546942 | 0.262 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.547313 | 0.262 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.549279 | 0.260 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 0.549279 | 0.260 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.549279 | 0.260 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.549279 | 0.260 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 0.549279 | 0.260 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 0.549279 | 0.260 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 0.549279 | 0.260 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 0.549279 | 0.260 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 0.549279 | 0.260 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.549279 | 0.260 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.549279 | 0.260 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.549279 | 0.260 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 0.549279 | 0.260 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 0.549279 | 0.260 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.550573 | 0.259 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.552702 | 0.258 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.552702 | 0.258 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.562382 | 0.250 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.562698 | 0.250 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.562698 | 0.250 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.563992 | 0.249 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.565448 | 0.248 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.567803 | 0.246 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 0.567803 | 0.246 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 0.567803 | 0.246 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.567803 | 0.246 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.571933 | 0.243 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.571933 | 0.243 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.571933 | 0.243 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.572754 | 0.242 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.574073 | 0.241 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.574587 | 0.241 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.575904 | 0.240 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.581354 | 0.236 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.581354 | 0.236 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 0.585568 | 0.232 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 0.585568 | 0.232 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 0.585568 | 0.232 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.586238 | 0.232 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.586238 | 0.232 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 0.586238 | 0.232 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.586238 | 0.232 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.586238 | 0.232 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.586238 | 0.232 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 0.586238 | 0.232 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.590643 | 0.229 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.597652 | 0.224 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 0.602603 | 0.220 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.602603 | 0.220 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.602603 | 0.220 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.602603 | 0.220 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 0.602603 | 0.220 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 0.602603 | 0.220 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.602603 | 0.220 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.603759 | 0.219 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.608818 | 0.216 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.608818 | 0.216 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 0.608827 | 0.216 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.608827 | 0.216 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 0.608827 | 0.216 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 0.608827 | 0.216 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.608827 | 0.216 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.611515 | 0.214 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.618939 | 0.208 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 0.618939 | 0.208 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 0.618939 | 0.208 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.618939 | 0.208 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 0.618939 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.618939 | 0.208 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 0.618939 | 0.208 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 0.618939 | 0.208 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 0.618939 | 0.208 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.619247 | 0.208 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.619764 | 0.208 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.624254 | 0.205 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 0.630465 | 0.200 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.630465 | 0.200 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.630465 | 0.200 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 0.634604 | 0.197 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.634604 | 0.197 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 0.634604 | 0.197 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 0.634604 | 0.197 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.634604 | 0.197 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.634604 | 0.197 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.634604 | 0.197 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.634604 | 0.197 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.635054 | 0.197 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.635455 | 0.197 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.639811 | 0.194 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 0.640929 | 0.193 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 0.640929 | 0.193 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.643522 | 0.191 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.643522 | 0.191 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.648862 | 0.188 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 0.649627 | 0.187 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 0.649627 | 0.187 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 0.649627 | 0.187 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 0.649627 | 0.187 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.649627 | 0.187 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 0.651158 | 0.186 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.651158 | 0.186 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.651158 | 0.186 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.651158 | 0.186 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.651850 | 0.186 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.659069 | 0.181 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.660038 | 0.180 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.661154 | 0.180 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.661154 | 0.180 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.662242 | 0.179 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.663116 | 0.178 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.664032 | 0.178 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.664032 | 0.178 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.664032 | 0.178 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 0.664032 | 0.178 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 0.664032 | 0.178 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.664032 | 0.178 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 0.664032 | 0.178 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.668087 | 0.175 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.668087 | 0.175 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.668168 | 0.175 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.669355 | 0.174 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.675995 | 0.170 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.677846 | 0.169 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.677846 | 0.169 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.677846 | 0.169 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.677846 | 0.169 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 0.677846 | 0.169 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.677846 | 0.169 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.677846 | 0.169 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.677846 | 0.169 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 0.677846 | 0.169 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 0.677846 | 0.169 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.677846 | 0.169 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.680314 | 0.167 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.680454 | 0.167 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.683749 | 0.165 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.688852 | 0.162 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.691093 | 0.160 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 0.691093 | 0.160 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.691093 | 0.160 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 0.691093 | 0.160 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 0.691093 | 0.160 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 0.691093 | 0.160 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 0.691093 | 0.160 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 0.691093 | 0.160 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.691393 | 0.160 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.698882 | 0.156 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.698882 | 0.156 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 0.703796 | 0.153 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 0.703796 | 0.153 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 0.703796 | 0.153 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 0.703796 | 0.153 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.703796 | 0.153 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.707710 | 0.150 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.707805 | 0.150 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.709854 | 0.149 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.713446 | 0.147 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.713446 | 0.147 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.713446 | 0.147 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 0.715978 | 0.145 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.715978 | 0.145 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 0.715978 | 0.145 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.716354 | 0.145 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.716354 | 0.145 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.716354 | 0.145 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.720521 | 0.142 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.721629 | 0.142 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.722304 | 0.141 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.724782 | 0.140 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 0.727659 | 0.138 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 0.727659 | 0.138 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.727659 | 0.138 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 0.727659 | 0.138 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 0.727659 | 0.138 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 0.727659 | 0.138 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 0.727659 | 0.138 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 0.727659 | 0.138 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.732997 | 0.135 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.738860 | 0.131 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.738860 | 0.131 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 0.738860 | 0.131 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 0.738860 | 0.131 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.738860 | 0.131 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.738860 | 0.131 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.738860 | 0.131 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.740229 | 0.131 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.740229 | 0.131 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.748803 | 0.126 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.748803 | 0.126 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.749602 | 0.125 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.749602 | 0.125 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 0.749602 | 0.125 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 0.749602 | 0.125 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.749602 | 0.125 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 0.749602 | 0.125 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.751684 | 0.124 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.751684 | 0.124 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.759902 | 0.119 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 0.759902 | 0.119 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.759902 | 0.119 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 0.759902 | 0.119 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 0.759902 | 0.119 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.759902 | 0.119 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 0.759902 | 0.119 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 0.759902 | 0.119 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 0.759902 | 0.119 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.762747 | 0.118 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.762747 | 0.118 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.763798 | 0.117 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.769779 | 0.114 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.769779 | 0.114 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.769779 | 0.114 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.769779 | 0.114 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.771000 | 0.113 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.772295 | 0.112 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.773424 | 0.112 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.777370 | 0.109 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.778010 | 0.109 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.778010 | 0.109 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.778010 | 0.109 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.778010 | 0.109 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.778010 | 0.109 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 0.778010 | 0.109 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.779250 | 0.108 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 0.779250 | 0.108 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 0.779250 | 0.108 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.779250 | 0.108 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.784832 | 0.105 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 0.788332 | 0.103 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.788332 | 0.103 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 0.788332 | 0.103 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 0.788332 | 0.103 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 0.788332 | 0.103 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 0.788332 | 0.103 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.789577 | 0.103 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.793638 | 0.100 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.793638 | 0.100 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.797041 | 0.099 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 0.797041 | 0.099 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 0.797041 | 0.099 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 0.797041 | 0.099 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.798101 | 0.098 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.798135 | 0.098 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.798460 | 0.098 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.800483 | 0.097 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.800483 | 0.097 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.800483 | 0.097 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.804201 | 0.095 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.805393 | 0.094 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 0.805393 | 0.094 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.805393 | 0.094 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.805393 | 0.094 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.805393 | 0.094 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.805393 | 0.094 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.810987 | 0.091 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 0.813401 | 0.090 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 0.813401 | 0.090 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 0.813401 | 0.090 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.815950 | 0.088 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.816996 | 0.088 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.820875 | 0.086 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.820875 | 0.086 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 0.821080 | 0.086 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 0.821080 | 0.086 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 0.821080 | 0.086 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.821080 | 0.086 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.821080 | 0.086 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 0.821080 | 0.086 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.821080 | 0.086 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.821080 | 0.086 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.822006 | 0.085 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.825503 | 0.083 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.827610 | 0.082 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.828443 | 0.082 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.828443 | 0.082 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 0.828443 | 0.082 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.828443 | 0.082 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.828443 | 0.082 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 0.828443 | 0.082 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.829706 | 0.081 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.834981 | 0.078 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.834981 | 0.078 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.834981 | 0.078 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.835504 | 0.078 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 0.835504 | 0.078 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.835504 | 0.078 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.835504 | 0.078 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.835504 | 0.078 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.838111 | 0.077 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.838344 | 0.077 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.838344 | 0.077 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.838344 | 0.077 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.838344 | 0.077 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.839466 | 0.076 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.842275 | 0.075 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 0.842275 | 0.075 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.842275 | 0.075 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 0.842275 | 0.075 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.843481 | 0.074 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.843481 | 0.074 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.843845 | 0.074 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.846737 | 0.072 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.848120 | 0.072 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.848470 | 0.071 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.848767 | 0.071 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.850193 | 0.070 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.854993 | 0.068 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.854993 | 0.068 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.854993 | 0.068 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 0.854993 | 0.068 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.856366 | 0.067 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.856913 | 0.067 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.860962 | 0.065 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.860962 | 0.065 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.860962 | 0.065 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.860962 | 0.065 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 0.860962 | 0.065 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.862579 | 0.064 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.862579 | 0.064 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 0.866687 | 0.062 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.866687 | 0.062 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.866687 | 0.062 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 0.866687 | 0.062 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 0.866687 | 0.062 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.867009 | 0.062 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.871307 | 0.060 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.871691 | 0.060 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.872175 | 0.059 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.872175 | 0.059 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.872175 | 0.059 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.872175 | 0.059 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 0.872175 | 0.059 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.872175 | 0.059 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.875289 | 0.058 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 0.875476 | 0.058 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 0.875476 | 0.058 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.877439 | 0.057 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.877439 | 0.057 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.877439 | 0.057 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.877439 | 0.057 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.878797 | 0.056 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.882218 | 0.054 | 0 | 0 |
| Defensins | R-HSA-1461973 | 0.882485 | 0.054 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 0.882485 | 0.054 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.882485 | 0.054 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.883222 | 0.054 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.885552 | 0.053 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.887250 | 0.052 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.887325 | 0.052 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.887325 | 0.052 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 0.887325 | 0.052 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 0.887325 | 0.052 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.889122 | 0.051 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 0.891965 | 0.050 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 0.891965 | 0.050 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.891965 | 0.050 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.891965 | 0.050 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.891965 | 0.050 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.891965 | 0.050 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.891965 | 0.050 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.894516 | 0.048 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.895055 | 0.048 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.896414 | 0.047 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 0.896414 | 0.047 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 0.896414 | 0.047 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 0.896414 | 0.047 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.897213 | 0.047 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.901305 | 0.045 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.903844 | 0.044 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.904604 | 0.044 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 0.904772 | 0.043 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 0.904772 | 0.043 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.907761 | 0.042 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 0.908695 | 0.042 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.910820 | 0.041 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 0.912456 | 0.040 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.913784 | 0.039 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.916063 | 0.038 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.916063 | 0.038 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.916063 | 0.038 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.916656 | 0.038 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.917024 | 0.038 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.917024 | 0.038 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.917127 | 0.038 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.918826 | 0.037 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.919330 | 0.037 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 0.919437 | 0.036 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.919437 | 0.036 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.919437 | 0.036 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.919521 | 0.036 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.919521 | 0.036 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.922837 | 0.035 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.924120 | 0.034 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.924120 | 0.034 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.925628 | 0.034 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.925628 | 0.034 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 0.926016 | 0.033 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.926016 | 0.033 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.927267 | 0.033 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.928412 | 0.032 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 0.929065 | 0.032 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.929065 | 0.032 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.934321 | 0.030 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.935962 | 0.029 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.935962 | 0.029 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.935979 | 0.029 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.937026 | 0.028 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.937479 | 0.028 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.937479 | 0.028 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.938636 | 0.028 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.938741 | 0.027 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 0.942527 | 0.026 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 0.942527 | 0.026 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 0.942527 | 0.026 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.944896 | 0.025 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.944896 | 0.025 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.944896 | 0.025 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.944896 | 0.025 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.948485 | 0.023 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.948485 | 0.023 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.950247 | 0.022 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.953437 | 0.021 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.953602 | 0.021 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.956220 | 0.019 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.961068 | 0.017 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.962060 | 0.017 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.963391 | 0.016 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 0.963834 | 0.016 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.963834 | 0.016 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 0.963834 | 0.016 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.968128 | 0.014 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 0.968128 | 0.014 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 0.969443 | 0.013 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.971700 | 0.012 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 0.973072 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 0.973072 | 0.012 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.975249 | 0.011 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.976257 | 0.010 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.978189 | 0.010 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.978248 | 0.010 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.980456 | 0.009 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.980932 | 0.008 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.980932 | 0.008 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.980932 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 0.981574 | 0.008 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.982106 | 0.008 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.982334 | 0.008 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 0.982412 | 0.008 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.984434 | 0.007 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.985077 | 0.007 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.985345 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.985735 | 0.006 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.986244 | 0.006 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.986284 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.986851 | 0.006 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.987810 | 0.005 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.987915 | 0.005 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.988893 | 0.005 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.989621 | 0.005 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.989792 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 0.990214 | 0.004 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 0.990845 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 0.991463 | 0.004 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 0.992267 | 0.003 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.992403 | 0.003 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.992403 | 0.003 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 0.992403 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.992403 | 0.003 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.993019 | 0.003 | 0 | 0 |
| Disease | R-HSA-1643685 | 0.993647 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.993883 | 0.003 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 0.994104 | 0.003 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.994265 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 0.994348 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.994581 | 0.002 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.994805 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.994814 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.995323 | 0.002 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 0.995337 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.995403 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.995613 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.995969 | 0.002 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.996003 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.996644 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.996996 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 0.997311 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.997468 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 0.997673 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 0.997951 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.997951 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.998117 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.998161 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.998234 | 0.001 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 0.998298 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 0.998399 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 0.998518 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 0.998695 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.999111 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 0.999226 | 0.000 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.999395 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 0.999668 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.999760 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 0.999761 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.999770 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 0.999865 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 0.999915 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 0.999962 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 0.999972 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 0.999975 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 0.999982 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 0.999982 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 0.999984 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 0.999984 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.999986 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 0.999997 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 0.999999 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 7.114254e-11 | 10.148 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.774224e-10 | 9.239 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.372811e-09 | 8.862 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.882581e-09 | 8.411 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.080709e-08 | 7.966 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.893542e-08 | 7.723 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.268960e-08 | 7.644 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.739315e-08 | 7.427 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.700496e-08 | 7.432 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.681068e-08 | 7.246 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.294332e-07 | 6.482 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.782079e-07 | 6.238 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.156499e-07 | 6.038 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.121493e-07 | 6.040 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.033211e-06 | 5.986 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.620621e-06 | 5.790 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.960210e-06 | 5.708 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.085874e-06 | 5.681 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.458107e-06 | 5.609 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.030092e-06 | 5.519 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.098613e-06 | 5.509 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.515167e-06 | 5.454 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.465723e-06 | 5.460 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.899401e-06 | 5.409 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.766319e-06 | 5.239 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.115192e-06 | 5.214 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.412988e-06 | 5.130 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.096560e-05 | 4.960 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.153101e-05 | 4.938 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.153101e-05 | 4.938 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.197111e-05 | 4.922 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.598787e-05 | 4.796 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.006458e-05 | 4.698 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.111467e-05 | 4.675 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.290769e-05 | 4.640 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.860375e-05 | 4.544 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.199663e-05 | 4.495 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.139619e-05 | 4.503 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.155470e-05 | 4.381 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.379737e-05 | 4.359 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.409351e-05 | 4.356 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.771320e-05 | 4.321 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.981436e-05 | 4.303 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.084228e-05 | 4.294 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.150864e-05 | 4.288 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.884862e-05 | 4.230 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.486536e-05 | 4.188 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.589703e-05 | 4.181 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.902698e-05 | 4.161 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.009059e-05 | 4.154 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 7.757955e-05 | 4.110 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.110582e-05 | 4.040 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.128111e-05 | 4.040 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.945968e-05 | 4.002 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.013242e-04 | 3.994 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.076087e-04 | 3.968 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.208566e-04 | 3.918 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.208566e-04 | 3.918 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.248415e-04 | 3.904 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.248415e-04 | 3.904 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.311690e-04 | 3.882 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.365278e-04 | 3.865 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.365278e-04 | 3.865 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.425212e-04 | 3.846 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.583973e-04 | 3.800 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.535361e-04 | 3.814 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.615747e-04 | 3.792 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.683773e-04 | 3.774 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.716117e-04 | 3.765 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.716117e-04 | 3.765 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.760113e-04 | 3.754 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.056104e-04 | 3.687 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.020218e-04 | 3.695 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.049041e-04 | 3.688 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.930883e-04 | 3.714 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.192053e-04 | 3.659 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.433284e-04 | 3.614 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.498811e-04 | 3.602 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.566227e-04 | 3.591 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.644695e-04 | 3.578 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.707281e-04 | 3.567 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.835461e-04 | 3.547 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.835461e-04 | 3.547 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.763074e-04 | 3.559 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.709329e-04 | 3.567 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.948216e-04 | 3.530 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.948216e-04 | 3.530 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.032269e-04 | 3.518 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.033801e-04 | 3.518 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.372387e-04 | 3.472 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.372387e-04 | 3.472 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.555156e-04 | 3.449 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.770367e-04 | 3.424 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.987552e-04 | 3.399 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.055322e-04 | 3.392 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.233294e-04 | 3.373 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.264953e-04 | 3.370 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.407292e-04 | 3.356 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.072214e-04 | 3.295 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.237732e-04 | 3.281 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.268329e-04 | 3.278 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.324304e-04 | 3.199 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.390886e-04 | 3.076 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.286642e-04 | 3.082 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.390886e-04 | 3.076 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.074822e-04 | 3.093 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.273585e-04 | 3.082 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.651971e-04 | 3.063 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.832290e-04 | 3.054 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.339903e-04 | 3.030 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.339903e-04 | 3.030 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.717433e-04 | 3.012 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.035719e-03 | 2.985 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.035719e-03 | 2.985 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.012085e-03 | 2.995 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.119771e-03 | 2.951 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.128887e-03 | 2.947 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.169759e-03 | 2.932 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.219803e-03 | 2.914 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.234840e-03 | 2.908 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.497225e-03 | 2.825 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.701862e-03 | 2.769 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.685313e-03 | 2.773 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.655709e-03 | 2.781 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.662095e-03 | 2.779 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.703675e-03 | 2.769 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.708030e-03 | 2.768 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.779936e-03 | 2.750 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.861494e-03 | 2.730 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.870971e-03 | 2.728 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.909014e-03 | 2.719 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.912160e-03 | 2.718 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.941267e-03 | 2.712 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.052121e-03 | 2.688 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.162411e-03 | 2.665 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.162411e-03 | 2.665 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.285967e-03 | 2.641 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.604372e-03 | 2.584 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.514014e-03 | 2.600 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.767789e-03 | 2.558 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.825068e-03 | 2.549 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.875906e-03 | 2.541 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.097710e-03 | 2.509 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.266593e-03 | 2.486 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.603100e-03 | 2.443 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.962115e-03 | 2.402 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.012893e-03 | 2.397 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.042690e-03 | 2.393 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.072091e-03 | 2.390 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.127435e-03 | 2.384 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.150538e-03 | 2.382 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.228859e-03 | 2.374 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.397295e-03 | 2.357 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.945871e-03 | 2.306 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.783927e-03 | 2.320 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.005690e-03 | 2.301 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.166315e-03 | 2.287 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.252246e-03 | 2.280 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.277454e-03 | 2.278 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.277454e-03 | 2.278 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.375492e-03 | 2.270 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.436974e-03 | 2.265 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.436974e-03 | 2.265 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.797105e-03 | 2.237 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.871271e-03 | 2.231 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.611686e-03 | 2.180 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.273599e-03 | 2.202 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.146141e-03 | 2.211 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.296035e-03 | 2.201 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.611686e-03 | 2.180 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.274024e-03 | 2.202 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.611686e-03 | 2.180 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.979039e-03 | 2.223 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.520429e-03 | 2.186 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.251703e-03 | 2.204 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.673173e-03 | 2.176 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.590922e-03 | 2.120 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.740404e-03 | 2.111 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.966093e-03 | 2.099 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.966093e-03 | 2.099 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.049540e-03 | 2.094 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.255470e-03 | 2.083 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.392131e-03 | 2.076 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.392131e-03 | 2.076 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.516947e-03 | 2.070 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.660971e-03 | 2.062 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.007076e-02 | 1.997 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.007076e-02 | 1.997 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.931560e-03 | 2.049 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.004637e-02 | 1.998 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.032515e-03 | 2.044 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.829185e-03 | 2.007 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.013752e-02 | 1.994 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.108311e-02 | 1.955 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.108311e-02 | 1.955 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.108311e-02 | 1.955 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.108311e-02 | 1.955 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.147104e-02 | 1.940 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.160000e-02 | 1.936 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.160000e-02 | 1.936 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.160000e-02 | 1.936 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.210358e-02 | 1.917 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.072677e-02 | 1.970 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.210358e-02 | 1.917 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.176358e-02 | 1.929 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.165559e-02 | 1.933 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.106438e-02 | 1.956 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.181267e-02 | 1.928 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.210358e-02 | 1.917 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.159388e-02 | 1.936 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.079214e-02 | 1.967 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.264797e-02 | 1.898 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.269630e-02 | 1.896 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.269630e-02 | 1.896 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.269630e-02 | 1.896 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.302707e-02 | 1.885 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.369995e-02 | 1.863 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.376435e-02 | 1.861 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.449267e-02 | 1.839 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.460127e-02 | 1.836 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.519390e-02 | 1.818 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.594431e-02 | 1.797 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.654143e-02 | 1.781 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.661923e-02 | 1.779 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.679981e-02 | 1.775 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.730528e-02 | 1.762 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.762392e-02 | 1.754 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.804045e-02 | 1.744 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.866870e-02 | 1.729 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.882890e-02 | 1.725 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.993004e-02 | 1.700 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.993004e-02 | 1.700 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.993004e-02 | 1.700 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.020350e-02 | 1.695 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.289753e-02 | 1.640 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.289753e-02 | 1.640 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.289753e-02 | 1.640 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.289753e-02 | 1.640 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.267893e-02 | 1.644 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.020350e-02 | 1.695 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.975037e-02 | 1.704 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.306031e-02 | 1.637 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.076060e-02 | 1.683 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.315451e-02 | 1.635 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.351679e-02 | 1.629 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.370001e-02 | 1.625 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.370001e-02 | 1.625 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.501166e-02 | 1.602 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.515799e-02 | 1.599 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.520562e-02 | 1.599 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.520562e-02 | 1.599 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.695059e-02 | 1.569 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.712472e-02 | 1.567 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.712472e-02 | 1.567 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.715037e-02 | 1.566 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.715037e-02 | 1.566 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.715037e-02 | 1.566 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.753574e-02 | 1.560 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.782743e-02 | 1.556 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.812994e-02 | 1.551 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.822868e-02 | 1.549 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.822868e-02 | 1.549 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.884984e-02 | 1.540 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.934999e-02 | 1.532 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.934999e-02 | 1.532 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.944925e-02 | 1.531 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.954629e-02 | 1.529 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.954629e-02 | 1.529 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.954629e-02 | 1.529 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.011743e-02 | 1.521 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.077306e-02 | 1.512 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.160379e-02 | 1.500 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.160611e-02 | 1.500 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.172450e-02 | 1.499 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.193355e-02 | 1.496 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.448710e-02 | 1.462 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.614145e-02 | 1.442 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.649200e-02 | 1.438 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.685304e-02 | 1.434 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.685304e-02 | 1.434 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.729821e-02 | 1.428 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.729821e-02 | 1.428 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.729821e-02 | 1.428 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.729821e-02 | 1.428 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.729821e-02 | 1.428 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.729821e-02 | 1.428 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.618698e-02 | 1.335 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.618698e-02 | 1.335 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.618698e-02 | 1.335 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.287026e-02 | 1.368 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.000892e-02 | 1.398 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.261063e-02 | 1.370 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.034485e-02 | 1.394 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.361456e-02 | 1.360 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.030343e-02 | 1.395 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.161612e-02 | 1.381 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.729821e-02 | 1.428 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.261063e-02 | 1.370 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.287026e-02 | 1.368 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.697497e-02 | 1.432 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.413421e-02 | 1.355 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.960832e-02 | 1.402 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.790287e-02 | 1.421 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.915747e-02 | 1.407 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.618698e-02 | 1.335 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.811486e-02 | 1.419 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.621259e-02 | 1.335 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.643107e-02 | 1.333 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.643107e-02 | 1.333 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.715682e-02 | 1.326 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.748572e-02 | 1.323 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.748572e-02 | 1.323 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.748572e-02 | 1.323 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.748572e-02 | 1.323 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.919734e-02 | 1.308 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.925122e-02 | 1.308 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.032580e-02 | 1.298 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.032580e-02 | 1.298 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.130216e-02 | 1.290 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.132088e-02 | 1.290 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.141054e-02 | 1.289 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.214929e-02 | 1.283 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.369203e-02 | 1.270 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.767877e-02 | 1.239 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.821280e-02 | 1.235 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.821280e-02 | 1.235 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.988500e-02 | 1.223 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.988500e-02 | 1.223 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.988500e-02 | 1.223 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.022885e-02 | 1.220 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.226429e-02 | 1.206 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.226429e-02 | 1.206 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.284321e-02 | 1.202 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.560178e-02 | 1.183 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.743167e-02 | 1.171 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.743167e-02 | 1.171 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.743167e-02 | 1.171 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.790392e-02 | 1.168 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.790392e-02 | 1.168 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.039577e-02 | 1.152 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.044817e-02 | 1.152 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.044817e-02 | 1.152 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.094425e-02 | 1.149 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.121412e-02 | 1.147 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.128564e-02 | 1.147 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.226775e-02 | 1.141 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.588668e-02 | 1.120 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 7.637752e-02 | 1.117 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.637752e-02 | 1.117 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.396464e-02 | 1.076 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 1.063304e-01 | 0.973 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.063304e-01 | 0.973 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.063304e-01 | 0.973 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 9.309787e-02 | 1.031 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.977837e-02 | 1.098 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.977837e-02 | 1.098 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.324529e-02 | 1.030 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.324529e-02 | 1.030 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.022117e-01 | 0.990 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.516649e-02 | 1.070 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.909856e-02 | 1.050 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.207775e-02 | 1.036 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.005564e-01 | 0.998 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.208123e-02 | 1.036 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.019630e-02 | 1.045 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.147112e-02 | 1.039 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.989664e-02 | 1.097 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.989664e-02 | 1.097 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 9.309787e-02 | 1.031 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.025348e-01 | 0.989 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.977837e-02 | 1.098 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.005564e-01 | 0.998 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.838239e-02 | 1.007 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.063304e-01 | 0.973 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.768382e-02 | 1.057 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.324529e-02 | 1.030 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.324529e-02 | 1.030 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.037912e-01 | 0.984 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.734465e-02 | 1.012 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.003035e-01 | 0.999 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.570166e-02 | 1.067 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.519766e-02 | 1.070 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.519766e-02 | 1.070 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.005229e-01 | 0.998 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.063304e-01 | 0.973 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.063304e-01 | 0.973 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.005229e-01 | 0.998 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.261874e-02 | 1.083 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.324529e-02 | 1.030 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.746394e-02 | 1.058 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.977837e-02 | 1.098 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.136023e-02 | 1.090 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.006849e-02 | 1.097 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.070016e-01 | 0.971 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.070016e-01 | 0.971 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.070016e-01 | 0.971 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.071498e-01 | 0.970 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.071498e-01 | 0.970 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.071498e-01 | 0.970 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.071498e-01 | 0.970 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.071498e-01 | 0.970 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.071498e-01 | 0.970 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.071498e-01 | 0.970 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.071498e-01 | 0.970 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.077948e-01 | 0.967 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.098986e-01 | 0.959 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.105846e-01 | 0.956 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.107634e-01 | 0.956 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.107634e-01 | 0.956 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.107634e-01 | 0.956 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.107634e-01 | 0.956 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.110296e-01 | 0.955 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 1.110296e-01 | 0.955 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.110296e-01 | 0.955 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.153389e-01 | 0.938 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.170417e-01 | 0.932 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.176746e-01 | 0.929 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.189407e-01 | 0.925 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.189407e-01 | 0.925 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.189407e-01 | 0.925 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.189407e-01 | 0.925 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.189407e-01 | 0.925 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.194747e-01 | 0.923 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 1.233783e-01 | 0.909 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 1.233783e-01 | 0.909 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.235217e-01 | 0.908 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.248172e-01 | 0.904 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.258479e-01 | 0.900 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.265463e-01 | 0.898 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.285853e-01 | 0.891 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.288723e-01 | 0.890 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.288723e-01 | 0.890 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.292675e-01 | 0.889 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.292675e-01 | 0.889 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.297926e-01 | 0.887 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.307284e-01 | 0.884 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.307284e-01 | 0.884 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.307284e-01 | 0.884 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 1.307284e-01 | 0.884 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.307284e-01 | 0.884 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.315362e-01 | 0.881 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.316946e-01 | 0.880 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.329964e-01 | 0.876 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.028241e-01 | 0.693 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.028241e-01 | 0.693 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.028241e-01 | 0.693 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.028241e-01 | 0.693 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.028241e-01 | 0.693 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.028241e-01 | 0.693 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.028241e-01 | 0.693 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.028241e-01 | 0.693 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.028241e-01 | 0.693 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.028241e-01 | 0.693 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.028241e-01 | 0.693 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.488620e-01 | 0.827 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.488620e-01 | 0.827 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.887963e-01 | 0.724 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.887963e-01 | 0.724 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.887963e-01 | 0.724 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.844354e-01 | 0.734 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.500654e-01 | 0.824 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.714525e-01 | 0.766 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.399377e-01 | 0.854 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.399377e-01 | 0.854 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.574071e-01 | 0.803 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.574071e-01 | 0.803 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.574071e-01 | 0.803 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.574071e-01 | 0.803 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.938176e-01 | 0.713 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.439615e-01 | 0.842 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.757139e-01 | 0.755 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.947803e-01 | 0.710 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.879531e-01 | 0.726 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.693496e-01 | 0.771 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.494214e-01 | 0.826 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.650564e-01 | 0.782 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.604313e-01 | 0.795 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.968672e-01 | 0.706 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.968672e-01 | 0.706 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.968672e-01 | 0.706 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.968672e-01 | 0.706 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.835926e-01 | 0.736 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.957133e-01 | 0.708 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.477170e-01 | 0.831 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.030293e-01 | 0.692 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.812562e-01 | 0.742 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.768336e-01 | 0.752 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.679821e-01 | 0.775 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.574071e-01 | 0.803 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.585975e-01 | 0.800 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.568629e-01 | 0.804 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.500654e-01 | 0.824 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.508371e-01 | 0.821 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.879531e-01 | 0.726 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 1.757139e-01 | 0.755 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.531091e-01 | 0.815 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.412290e-01 | 0.850 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.844354e-01 | 0.734 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.585125e-01 | 0.800 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.447643e-01 | 0.839 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.574071e-01 | 0.803 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.879531e-01 | 0.726 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.828837e-01 | 0.738 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.957133e-01 | 0.708 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.883365e-01 | 0.725 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.403805e-01 | 0.853 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.574071e-01 | 0.803 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.840465e-01 | 0.735 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.558309e-01 | 0.807 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.787342e-01 | 0.748 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.887963e-01 | 0.724 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.585975e-01 | 0.800 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.709153e-01 | 0.767 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.714525e-01 | 0.766 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.374525e-01 | 0.862 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.935089e-01 | 0.713 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.727560e-01 | 0.763 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.968672e-01 | 0.706 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.845153e-01 | 0.734 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.395893e-01 | 0.855 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.754769e-01 | 0.756 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.718266e-01 | 0.765 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.460473e-01 | 0.836 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.757139e-01 | 0.755 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.773985e-01 | 0.751 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.531657e-01 | 0.815 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.883365e-01 | 0.725 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.883365e-01 | 0.725 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.902080e-01 | 0.721 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.902080e-01 | 0.721 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.662118e-01 | 0.779 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.778486e-01 | 0.750 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.604313e-01 | 0.795 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.532441e-01 | 0.815 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.754769e-01 | 0.756 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.650564e-01 | 0.782 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.526354e-01 | 0.816 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.513649e-01 | 0.820 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.033719e-01 | 0.692 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.034051e-01 | 0.692 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.034051e-01 | 0.692 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.053951e-01 | 0.687 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.092460e-01 | 0.679 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.095052e-01 | 0.679 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.103251e-01 | 0.677 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.131538e-01 | 0.671 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.143297e-01 | 0.669 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.143297e-01 | 0.669 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.145250e-01 | 0.669 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.168986e-01 | 0.664 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.193223e-01 | 0.659 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.208297e-01 | 0.656 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.238497e-01 | 0.650 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.260682e-01 | 0.646 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.273282e-01 | 0.643 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.284734e-01 | 0.641 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.287082e-01 | 0.641 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.299482e-01 | 0.638 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.299482e-01 | 0.638 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.299482e-01 | 0.638 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.299482e-01 | 0.638 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.299482e-01 | 0.638 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.348639e-01 | 0.629 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.356645e-01 | 0.628 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.375486e-01 | 0.624 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.376933e-01 | 0.624 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.376933e-01 | 0.624 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.389743e-01 | 0.622 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.409238e-01 | 0.618 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.418181e-01 | 0.617 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.427382e-01 | 0.615 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.449440e-01 | 0.611 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.449440e-01 | 0.611 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.459110e-01 | 0.609 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.882513e-01 | 0.540 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.882513e-01 | 0.540 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.882513e-01 | 0.540 | 0 | 0 |
| Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | R-HSA-5619045 | 2.882513e-01 | 0.540 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.882513e-01 | 0.540 | 0 | 0 |
| Defective SLC34A2 causes PALM | R-HSA-5687583 | 2.882513e-01 | 0.540 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.645285e-01 | 0.438 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.645285e-01 | 0.438 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.645285e-01 | 0.438 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.645285e-01 | 0.438 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.715989e-01 | 0.566 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.715989e-01 | 0.566 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.131693e-01 | 0.504 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.326351e-01 | 0.364 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.326351e-01 | 0.364 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.326351e-01 | 0.364 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.326351e-01 | 0.364 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.729253e-01 | 0.564 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.541986e-01 | 0.451 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.541986e-01 | 0.451 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.541986e-01 | 0.451 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.541986e-01 | 0.451 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.541986e-01 | 0.451 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.541986e-01 | 0.451 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.653862e-01 | 0.576 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.557120e-01 | 0.592 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.557120e-01 | 0.592 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.902736e-01 | 0.537 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.341530e-01 | 0.476 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.943257e-01 | 0.404 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.943257e-01 | 0.404 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.943257e-01 | 0.404 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.943257e-01 | 0.404 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.943257e-01 | 0.404 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.943257e-01 | 0.404 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.934459e-01 | 0.307 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.934459e-01 | 0.307 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.934459e-01 | 0.307 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 4.934459e-01 | 0.307 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.934459e-01 | 0.307 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 4.934459e-01 | 0.307 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.934459e-01 | 0.307 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.934459e-01 | 0.307 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.934459e-01 | 0.307 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.934459e-01 | 0.307 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.934459e-01 | 0.307 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.154558e-01 | 0.501 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.647704e-01 | 0.438 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.647704e-01 | 0.438 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.647704e-01 | 0.438 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.647704e-01 | 0.438 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.833457e-01 | 0.548 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.332728e-01 | 0.363 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.204608e-01 | 0.494 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.567096e-01 | 0.591 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.868160e-01 | 0.542 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.662167e-01 | 0.436 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.662167e-01 | 0.436 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.594123e-01 | 0.586 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.646411e-01 | 0.438 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.915701e-01 | 0.407 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.251200e-01 | 0.371 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.708321e-01 | 0.327 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.889156e-01 | 0.539 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.889156e-01 | 0.539 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.402397e-01 | 0.468 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.402397e-01 | 0.468 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.167690e-01 | 0.380 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.545599e-01 | 0.342 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.545599e-01 | 0.342 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.102362e-01 | 0.508 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.714550e-01 | 0.430 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.417217e-01 | 0.355 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.833490e-01 | 0.316 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.833490e-01 | 0.316 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.833490e-01 | 0.316 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.663455e-01 | 0.331 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.663455e-01 | 0.331 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.663455e-01 | 0.331 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.706954e-01 | 0.568 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.470530e-01 | 0.350 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.725704e-01 | 0.326 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.926174e-01 | 0.307 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.488977e-01 | 0.604 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.592512e-01 | 0.586 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.809446e-01 | 0.318 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.653862e-01 | 0.576 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.251200e-01 | 0.371 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.653862e-01 | 0.576 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.545599e-01 | 0.342 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.947661e-01 | 0.404 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.341530e-01 | 0.476 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 2.985943e-01 | 0.525 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 3.408090e-01 | 0.467 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.653862e-01 | 0.576 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.139146e-01 | 0.503 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 3.034711e-01 | 0.518 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.154558e-01 | 0.501 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.332728e-01 | 0.363 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.332728e-01 | 0.363 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.868160e-01 | 0.542 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.915701e-01 | 0.407 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.545599e-01 | 0.342 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.507663e-01 | 0.455 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.729253e-01 | 0.564 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.951450e-01 | 0.403 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.951450e-01 | 0.403 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.951450e-01 | 0.403 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.153024e-01 | 0.501 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.541986e-01 | 0.451 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.934459e-01 | 0.307 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.647704e-01 | 0.438 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.646411e-01 | 0.438 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.881845e-01 | 0.540 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.881845e-01 | 0.540 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.546211e-01 | 0.450 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.417217e-01 | 0.355 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.759351e-01 | 0.425 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.935099e-01 | 0.532 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.905660e-01 | 0.309 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.833457e-01 | 0.548 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.914652e-01 | 0.407 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.557120e-01 | 0.592 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.902736e-01 | 0.537 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.523895e-01 | 0.598 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.047982e-01 | 0.516 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.662167e-01 | 0.436 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.769837e-01 | 0.558 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.204608e-01 | 0.494 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.541986e-01 | 0.451 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.943257e-01 | 0.404 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.408090e-01 | 0.467 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.044299e-01 | 0.517 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.545599e-01 | 0.342 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.978789e-01 | 0.526 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.527417e-01 | 0.344 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.803401e-01 | 0.318 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.199298e-01 | 0.377 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.617926e-01 | 0.442 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.833457e-01 | 0.548 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.951450e-01 | 0.403 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.647704e-01 | 0.438 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.617926e-01 | 0.442 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.770511e-01 | 0.321 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.947661e-01 | 0.404 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.541986e-01 | 0.451 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 2.902736e-01 | 0.537 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.567096e-01 | 0.591 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.885302e-01 | 0.540 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.708321e-01 | 0.327 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.803401e-01 | 0.318 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.221737e-01 | 0.375 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.583491e-01 | 0.446 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.044299e-01 | 0.517 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.412413e-01 | 0.355 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.044299e-01 | 0.517 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.583491e-01 | 0.446 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.744261e-01 | 0.562 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.204608e-01 | 0.494 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.222523e-01 | 0.492 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.385610e-01 | 0.358 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.315882e-01 | 0.479 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.647704e-01 | 0.438 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 4.663455e-01 | 0.331 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.617620e-01 | 0.442 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.882513e-01 | 0.540 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.882513e-01 | 0.540 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.645285e-01 | 0.438 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.645285e-01 | 0.438 | 0 | 0 |
| Type II Na+/Pi cotransporters | R-HSA-427589 | 4.326351e-01 | 0.364 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.541986e-01 | 0.451 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.034711e-01 | 0.518 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.341530e-01 | 0.476 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.943257e-01 | 0.404 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.934459e-01 | 0.307 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.934459e-01 | 0.307 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.951450e-01 | 0.403 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.425024e-01 | 0.465 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.402397e-01 | 0.468 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.816933e-01 | 0.418 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.089168e-01 | 0.388 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.765382e-01 | 0.424 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.947661e-01 | 0.404 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.140562e-01 | 0.383 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.571599e-01 | 0.590 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.567096e-01 | 0.591 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.714550e-01 | 0.430 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.769837e-01 | 0.558 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.161373e-01 | 0.381 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.905660e-01 | 0.309 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.653862e-01 | 0.576 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 4.251200e-01 | 0.371 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.136100e-01 | 0.383 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.833457e-01 | 0.548 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.332728e-01 | 0.363 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.583491e-01 | 0.446 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.417217e-01 | 0.355 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.044992e-01 | 0.393 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.296579e-01 | 0.367 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.044299e-01 | 0.517 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.951450e-01 | 0.403 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.524401e-01 | 0.453 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.833490e-01 | 0.316 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.369159e-01 | 0.472 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.715989e-01 | 0.566 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.222263e-01 | 0.492 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 4.251200e-01 | 0.371 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.803401e-01 | 0.318 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.803401e-01 | 0.318 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.748493e-01 | 0.561 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.765382e-01 | 0.424 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.016015e-01 | 0.396 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.715989e-01 | 0.566 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.326351e-01 | 0.364 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.943257e-01 | 0.404 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.934459e-01 | 0.307 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.332728e-01 | 0.363 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.026716e-01 | 0.519 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.741426e-01 | 0.562 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.947661e-01 | 0.404 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.309171e-01 | 0.366 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.527417e-01 | 0.344 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.412413e-01 | 0.355 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.591535e-01 | 0.586 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.658360e-01 | 0.437 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.495508e-01 | 0.603 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.016635e-01 | 0.520 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.480325e-01 | 0.458 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.567096e-01 | 0.591 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.724893e-01 | 0.565 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.920305e-01 | 0.535 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.914652e-01 | 0.407 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.672926e-01 | 0.330 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.807223e-01 | 0.419 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.394469e-01 | 0.357 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.412413e-01 | 0.355 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.617926e-01 | 0.442 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.326351e-01 | 0.364 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.868028e-01 | 0.413 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.616660e-01 | 0.442 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.214667e-01 | 0.375 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.947661e-01 | 0.404 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.947661e-01 | 0.404 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.833490e-01 | 0.316 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.459995e-01 | 0.461 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.131693e-01 | 0.504 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.943257e-01 | 0.404 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.934459e-01 | 0.307 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.332728e-01 | 0.363 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 3.646411e-01 | 0.438 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.617926e-01 | 0.442 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.985943e-01 | 0.525 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.883464e-01 | 0.411 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.412413e-01 | 0.355 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.608799e-01 | 0.336 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.798174e-01 | 0.319 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.943257e-01 | 0.404 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.708321e-01 | 0.327 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.743337e-01 | 0.324 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.663455e-01 | 0.331 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.605377e-01 | 0.584 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.332728e-01 | 0.363 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.425024e-01 | 0.465 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.251200e-01 | 0.371 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 4.743337e-01 | 0.324 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.507663e-01 | 0.455 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.545599e-01 | 0.342 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.390477e-01 | 0.357 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.943257e-01 | 0.404 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.390477e-01 | 0.357 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.204225e-01 | 0.494 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.332728e-01 | 0.363 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.956406e-01 | 0.305 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.956406e-01 | 0.305 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.956406e-01 | 0.305 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.956406e-01 | 0.305 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.956406e-01 | 0.305 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.956406e-01 | 0.305 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.995826e-01 | 0.301 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.028309e-01 | 0.299 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.028309e-01 | 0.299 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.030844e-01 | 0.298 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.056125e-01 | 0.296 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.056125e-01 | 0.296 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.056125e-01 | 0.296 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.056125e-01 | 0.296 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.056125e-01 | 0.296 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.068539e-01 | 0.295 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.068539e-01 | 0.295 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.068539e-01 | 0.295 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.068539e-01 | 0.295 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.068539e-01 | 0.295 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.068539e-01 | 0.295 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.068539e-01 | 0.295 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.068539e-01 | 0.295 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.113904e-01 | 0.291 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.113904e-01 | 0.291 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.113904e-01 | 0.291 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.113904e-01 | 0.291 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.113904e-01 | 0.291 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.143179e-01 | 0.289 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.143179e-01 | 0.289 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.143179e-01 | 0.289 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.143179e-01 | 0.289 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.143179e-01 | 0.289 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.143179e-01 | 0.289 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.158023e-01 | 0.288 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.166148e-01 | 0.287 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.166148e-01 | 0.287 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.166148e-01 | 0.287 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.166148e-01 | 0.287 | 0 | 0 |
| Translation | R-HSA-72766 | 5.194046e-01 | 0.284 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.203084e-01 | 0.284 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.218909e-01 | 0.282 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.218909e-01 | 0.282 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.218909e-01 | 0.282 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.247277e-01 | 0.280 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.260230e-01 | 0.279 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.372134e-01 | 0.270 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 5.372712e-01 | 0.270 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.375440e-01 | 0.270 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.375440e-01 | 0.270 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.375440e-01 | 0.270 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.375440e-01 | 0.270 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.375440e-01 | 0.270 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.375440e-01 | 0.270 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.379774e-01 | 0.269 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.379774e-01 | 0.269 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.384892e-01 | 0.269 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.386045e-01 | 0.269 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.412361e-01 | 0.267 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.412361e-01 | 0.267 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.412361e-01 | 0.267 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.412361e-01 | 0.267 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.412361e-01 | 0.267 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.412361e-01 | 0.267 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.412361e-01 | 0.267 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.477422e-01 | 0.261 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.477422e-01 | 0.261 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.477422e-01 | 0.261 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 5.477422e-01 | 0.261 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.477422e-01 | 0.261 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.477422e-01 | 0.261 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.477422e-01 | 0.261 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.477422e-01 | 0.261 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.477422e-01 | 0.261 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.477422e-01 | 0.261 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.477422e-01 | 0.261 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.477422e-01 | 0.261 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.477422e-01 | 0.261 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.530433e-01 | 0.257 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.538509e-01 | 0.257 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.573983e-01 | 0.254 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.573983e-01 | 0.254 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.583003e-01 | 0.253 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.601950e-01 | 0.252 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.601950e-01 | 0.252 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.601950e-01 | 0.252 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.601950e-01 | 0.252 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.649274e-01 | 0.248 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.649274e-01 | 0.248 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.649274e-01 | 0.248 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.649274e-01 | 0.248 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.649274e-01 | 0.248 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.681949e-01 | 0.246 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.712562e-01 | 0.243 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.739166e-01 | 0.241 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.739166e-01 | 0.241 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.739166e-01 | 0.241 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.739166e-01 | 0.241 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.739166e-01 | 0.241 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.739166e-01 | 0.241 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.755056e-01 | 0.240 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.778225e-01 | 0.238 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.810531e-01 | 0.236 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.822294e-01 | 0.235 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.822294e-01 | 0.235 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.822294e-01 | 0.235 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.876678e-01 | 0.231 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.876678e-01 | 0.231 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.903099e-01 | 0.229 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.903099e-01 | 0.229 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.903099e-01 | 0.229 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.903099e-01 | 0.229 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 5.903099e-01 | 0.229 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.903099e-01 | 0.229 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.903099e-01 | 0.229 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 5.903099e-01 | 0.229 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.911531e-01 | 0.228 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.962214e-01 | 0.225 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.962214e-01 | 0.225 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.962214e-01 | 0.225 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.962214e-01 | 0.225 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.962214e-01 | 0.225 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.962214e-01 | 0.225 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.962214e-01 | 0.225 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.962214e-01 | 0.225 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.962214e-01 | 0.225 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.962214e-01 | 0.225 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.962214e-01 | 0.225 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.962214e-01 | 0.225 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.962214e-01 | 0.225 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.962214e-01 | 0.225 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.962214e-01 | 0.225 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.963970e-01 | 0.224 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.963970e-01 | 0.224 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.963970e-01 | 0.224 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.963970e-01 | 0.224 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.970479e-01 | 0.224 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.970479e-01 | 0.224 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.034755e-01 | 0.219 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.036128e-01 | 0.219 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.036128e-01 | 0.219 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.048650e-01 | 0.218 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.048650e-01 | 0.218 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.048650e-01 | 0.218 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.048650e-01 | 0.218 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.048650e-01 | 0.218 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.048650e-01 | 0.218 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.048650e-01 | 0.218 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.055706e-01 | 0.218 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.073442e-01 | 0.217 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.129821e-01 | 0.213 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.147158e-01 | 0.211 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.151566e-01 | 0.211 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.151566e-01 | 0.211 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.151566e-01 | 0.211 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.195190e-01 | 0.208 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.243177e-01 | 0.205 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.243177e-01 | 0.205 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.243177e-01 | 0.205 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.243177e-01 | 0.205 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.243177e-01 | 0.205 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.254942e-01 | 0.204 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.259993e-01 | 0.203 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.294017e-01 | 0.201 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.304759e-01 | 0.200 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.333940e-01 | 0.198 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.333940e-01 | 0.198 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.340772e-01 | 0.198 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.340772e-01 | 0.198 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.340772e-01 | 0.198 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.340772e-01 | 0.198 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.340772e-01 | 0.198 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.340772e-01 | 0.198 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.340772e-01 | 0.198 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.340772e-01 | 0.198 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.340772e-01 | 0.198 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.340772e-01 | 0.198 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.349273e-01 | 0.197 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.381205e-01 | 0.195 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.384944e-01 | 0.195 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.395065e-01 | 0.194 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.395065e-01 | 0.194 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.395065e-01 | 0.194 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.395065e-01 | 0.194 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.395065e-01 | 0.194 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.395065e-01 | 0.194 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.395065e-01 | 0.194 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.395065e-01 | 0.194 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.395065e-01 | 0.194 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.395065e-01 | 0.194 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.395065e-01 | 0.194 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.395065e-01 | 0.194 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.395065e-01 | 0.194 | 0 | 0 |
| Metabolism of vitamin K | R-HSA-6806664 | 6.395065e-01 | 0.194 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.395065e-01 | 0.194 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.395065e-01 | 0.194 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.395065e-01 | 0.194 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.419311e-01 | 0.193 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.443226e-01 | 0.191 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.443226e-01 | 0.191 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.443226e-01 | 0.191 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.443226e-01 | 0.191 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.453301e-01 | 0.190 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.508197e-01 | 0.187 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.510920e-01 | 0.186 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.517769e-01 | 0.186 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.605095e-01 | 0.180 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.605095e-01 | 0.180 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.615697e-01 | 0.179 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.615697e-01 | 0.179 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.615697e-01 | 0.179 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.615697e-01 | 0.179 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.636121e-01 | 0.178 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.682374e-01 | 0.175 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.682374e-01 | 0.175 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.682374e-01 | 0.175 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.711740e-01 | 0.173 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.726026e-01 | 0.172 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.781537e-01 | 0.169 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.781537e-01 | 0.169 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.781537e-01 | 0.169 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.781537e-01 | 0.169 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.781537e-01 | 0.169 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 6.781537e-01 | 0.169 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.781537e-01 | 0.169 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.781537e-01 | 0.169 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.781537e-01 | 0.169 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.781537e-01 | 0.169 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.781537e-01 | 0.169 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.781537e-01 | 0.169 | 0 | 0 |
| Reuptake of GABA | R-HSA-888593 | 6.781537e-01 | 0.169 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.781537e-01 | 0.169 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.781537e-01 | 0.169 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.781537e-01 | 0.169 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.781537e-01 | 0.169 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.781537e-01 | 0.169 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.781537e-01 | 0.169 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.789349e-01 | 0.168 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.818777e-01 | 0.166 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.818777e-01 | 0.166 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.821602e-01 | 0.166 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.821757e-01 | 0.166 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.821757e-01 | 0.166 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.821757e-01 | 0.166 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.844288e-01 | 0.165 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.848202e-01 | 0.164 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.862328e-01 | 0.164 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.873755e-01 | 0.163 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.873755e-01 | 0.163 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 6.873755e-01 | 0.163 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 6.873755e-01 | 0.163 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.873755e-01 | 0.163 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.873755e-01 | 0.163 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.873755e-01 | 0.163 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.873755e-01 | 0.163 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.873755e-01 | 0.163 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.928346e-01 | 0.159 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.000081e-01 | 0.155 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.000081e-01 | 0.155 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.008336e-01 | 0.154 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.008336e-01 | 0.154 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.022275e-01 | 0.154 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.022275e-01 | 0.154 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.022275e-01 | 0.154 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.022275e-01 | 0.154 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.022275e-01 | 0.154 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.063385e-01 | 0.151 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.099579e-01 | 0.149 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.099579e-01 | 0.149 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.115401e-01 | 0.148 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.115401e-01 | 0.148 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.115401e-01 | 0.148 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.115401e-01 | 0.148 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.115401e-01 | 0.148 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.115401e-01 | 0.148 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.115401e-01 | 0.148 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.126597e-01 | 0.147 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.126597e-01 | 0.147 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.126597e-01 | 0.147 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.126597e-01 | 0.147 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.126597e-01 | 0.147 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.126597e-01 | 0.147 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.126597e-01 | 0.147 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.126597e-01 | 0.147 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.126597e-01 | 0.147 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.126597e-01 | 0.147 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.126597e-01 | 0.147 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.162737e-01 | 0.145 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.171081e-01 | 0.144 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.171081e-01 | 0.144 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.215683e-01 | 0.142 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.260033e-01 | 0.139 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.309988e-01 | 0.136 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.311393e-01 | 0.136 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.322292e-01 | 0.135 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.334784e-01 | 0.135 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.334784e-01 | 0.135 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.341189e-01 | 0.134 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.341189e-01 | 0.134 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.341189e-01 | 0.134 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.341189e-01 | 0.134 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.341189e-01 | 0.134 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.341189e-01 | 0.134 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.341189e-01 | 0.134 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.365267e-01 | 0.133 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.365267e-01 | 0.133 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.395138e-01 | 0.131 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.399153e-01 | 0.131 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.434680e-01 | 0.129 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.434680e-01 | 0.129 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.434680e-01 | 0.129 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.434680e-01 | 0.129 | 0 | 0 |
| Enzymatic degradation of Dopamine by monoamine oxidase | R-HSA-379398 | 7.434680e-01 | 0.129 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.434680e-01 | 0.129 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.434680e-01 | 0.129 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.434680e-01 | 0.129 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.434680e-01 | 0.129 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.434680e-01 | 0.129 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.434680e-01 | 0.129 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.434680e-01 | 0.129 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.434680e-01 | 0.129 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.434680e-01 | 0.129 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.441991e-01 | 0.128 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.454318e-01 | 0.128 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.454318e-01 | 0.128 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.454318e-01 | 0.128 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.456163e-01 | 0.127 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.491252e-01 | 0.125 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.491252e-01 | 0.125 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.496078e-01 | 0.125 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.551739e-01 | 0.122 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.551739e-01 | 0.122 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.551739e-01 | 0.122 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.551739e-01 | 0.122 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.551739e-01 | 0.122 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.551739e-01 | 0.122 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.567977e-01 | 0.121 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.569264e-01 | 0.121 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.572883e-01 | 0.121 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.572883e-01 | 0.121 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.634128e-01 | 0.117 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.640578e-01 | 0.117 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.640578e-01 | 0.117 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.709747e-01 | 0.113 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.709747e-01 | 0.113 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.709747e-01 | 0.113 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.709747e-01 | 0.113 | 0 | 0 |
| Enzymatic degradation of dopamine by COMT | R-HSA-379397 | 7.709747e-01 | 0.113 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.709747e-01 | 0.113 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.709747e-01 | 0.113 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.709747e-01 | 0.113 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.709747e-01 | 0.113 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.709747e-01 | 0.113 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.709747e-01 | 0.113 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.709747e-01 | 0.113 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.709747e-01 | 0.113 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.709747e-01 | 0.113 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.709747e-01 | 0.113 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.709747e-01 | 0.113 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.709747e-01 | 0.113 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.709747e-01 | 0.113 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.723133e-01 | 0.112 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.723133e-01 | 0.112 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.723133e-01 | 0.112 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.723679e-01 | 0.112 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.737112e-01 | 0.111 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.747724e-01 | 0.111 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.747724e-01 | 0.111 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.747724e-01 | 0.111 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.748221e-01 | 0.111 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.781625e-01 | 0.109 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.782880e-01 | 0.109 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.782880e-01 | 0.109 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.782880e-01 | 0.109 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.852612e-01 | 0.105 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.877904e-01 | 0.104 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.880190e-01 | 0.103 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.880190e-01 | 0.103 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.892114e-01 | 0.103 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.892114e-01 | 0.103 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.927811e-01 | 0.101 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.929846e-01 | 0.101 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.929846e-01 | 0.101 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.929846e-01 | 0.101 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.955335e-01 | 0.099 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.955335e-01 | 0.099 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.955335e-01 | 0.099 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.955335e-01 | 0.099 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.955335e-01 | 0.099 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.955335e-01 | 0.099 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 7.955335e-01 | 0.099 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.955335e-01 | 0.099 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.955335e-01 | 0.099 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 7.955335e-01 | 0.099 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.955335e-01 | 0.099 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.955335e-01 | 0.099 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.999016e-01 | 0.097 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.046996e-01 | 0.094 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.067890e-01 | 0.093 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.098823e-01 | 0.092 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.098823e-01 | 0.092 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.098823e-01 | 0.092 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.141451e-01 | 0.089 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.169148e-01 | 0.088 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.174600e-01 | 0.088 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.174600e-01 | 0.088 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.174600e-01 | 0.088 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.174600e-01 | 0.088 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.174600e-01 | 0.088 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.174600e-01 | 0.088 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.174600e-01 | 0.088 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.174600e-01 | 0.088 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.174600e-01 | 0.088 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.174600e-01 | 0.088 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.174600e-01 | 0.088 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.174600e-01 | 0.088 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.174600e-01 | 0.088 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.175646e-01 | 0.087 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.175646e-01 | 0.087 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.175646e-01 | 0.087 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.183376e-01 | 0.087 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.235691e-01 | 0.084 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.255379e-01 | 0.083 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 8.255379e-01 | 0.083 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 8.255379e-01 | 0.083 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.255379e-01 | 0.083 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.255379e-01 | 0.083 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.258930e-01 | 0.083 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.261604e-01 | 0.083 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.262865e-01 | 0.083 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.284877e-01 | 0.082 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.284945e-01 | 0.082 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.286554e-01 | 0.082 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.304825e-01 | 0.081 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.361143e-01 | 0.078 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.366885e-01 | 0.077 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.370364e-01 | 0.077 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.370364e-01 | 0.077 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.370364e-01 | 0.077 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.370364e-01 | 0.077 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.370364e-01 | 0.077 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.370364e-01 | 0.077 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.370364e-01 | 0.077 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.370364e-01 | 0.077 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.370364e-01 | 0.077 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.370364e-01 | 0.077 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.370364e-01 | 0.077 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.370364e-01 | 0.077 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.370364e-01 | 0.077 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.370364e-01 | 0.077 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.370364e-01 | 0.077 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.370364e-01 | 0.077 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.370364e-01 | 0.077 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.370364e-01 | 0.077 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.370364e-01 | 0.077 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.370364e-01 | 0.077 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.370364e-01 | 0.077 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.394588e-01 | 0.076 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.394588e-01 | 0.076 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.394588e-01 | 0.076 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.399270e-01 | 0.076 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.399270e-01 | 0.076 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.400236e-01 | 0.076 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.400236e-01 | 0.076 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.400236e-01 | 0.076 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.400236e-01 | 0.076 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.400236e-01 | 0.076 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.400236e-01 | 0.076 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.426066e-01 | 0.074 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.426066e-01 | 0.074 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.426066e-01 | 0.074 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.426066e-01 | 0.074 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.481661e-01 | 0.072 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.494166e-01 | 0.071 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.508207e-01 | 0.070 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.534100e-01 | 0.069 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.534100e-01 | 0.069 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.534100e-01 | 0.069 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.538461e-01 | 0.069 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.539579e-01 | 0.069 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.545143e-01 | 0.068 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.545143e-01 | 0.068 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.545143e-01 | 0.068 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.545143e-01 | 0.068 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.545143e-01 | 0.068 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.545143e-01 | 0.068 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.545143e-01 | 0.068 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.545143e-01 | 0.068 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.545143e-01 | 0.068 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.545143e-01 | 0.068 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.565400e-01 | 0.067 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.578252e-01 | 0.067 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.596253e-01 | 0.066 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.635411e-01 | 0.064 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.644907e-01 | 0.063 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.646132e-01 | 0.063 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.657663e-01 | 0.063 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.657663e-01 | 0.063 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.657663e-01 | 0.063 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.657663e-01 | 0.063 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.672829e-01 | 0.062 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.701186e-01 | 0.060 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 8.701186e-01 | 0.060 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.701186e-01 | 0.060 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.701186e-01 | 0.060 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.701186e-01 | 0.060 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.701186e-01 | 0.060 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.701186e-01 | 0.060 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.701186e-01 | 0.060 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.701186e-01 | 0.060 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.701186e-01 | 0.060 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.701281e-01 | 0.060 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.712017e-01 | 0.060 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.771595e-01 | 0.057 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.771595e-01 | 0.057 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.818298e-01 | 0.055 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.820459e-01 | 0.055 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.828128e-01 | 0.054 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.828128e-01 | 0.054 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.838638e-01 | 0.054 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.840501e-01 | 0.054 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.840501e-01 | 0.054 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.840501e-01 | 0.054 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.840501e-01 | 0.054 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.840501e-01 | 0.054 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.840501e-01 | 0.054 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.840501e-01 | 0.054 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.840501e-01 | 0.054 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.840501e-01 | 0.054 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.840501e-01 | 0.054 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.840501e-01 | 0.054 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.857973e-01 | 0.053 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.862629e-01 | 0.052 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.876538e-01 | 0.052 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.876538e-01 | 0.052 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.876538e-01 | 0.052 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.890854e-01 | 0.051 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.900988e-01 | 0.051 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.909149e-01 | 0.050 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.925420e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.935224e-01 | 0.049 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.964879e-01 | 0.047 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.964879e-01 | 0.047 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.964879e-01 | 0.047 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.964879e-01 | 0.047 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.964879e-01 | 0.047 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.964879e-01 | 0.047 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.964879e-01 | 0.047 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.964879e-01 | 0.047 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.969913e-01 | 0.047 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.973111e-01 | 0.047 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.973111e-01 | 0.047 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.973111e-01 | 0.047 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.075622e-01 | 0.042 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.075923e-01 | 0.042 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.075923e-01 | 0.042 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.075923e-01 | 0.042 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.075923e-01 | 0.042 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.075923e-01 | 0.042 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.075923e-01 | 0.042 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.075923e-01 | 0.042 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.081713e-01 | 0.042 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.088254e-01 | 0.042 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.096588e-01 | 0.041 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.096588e-01 | 0.041 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.098660e-01 | 0.041 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.098660e-01 | 0.041 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.140081e-01 | 0.039 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.143466e-01 | 0.039 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.143466e-01 | 0.039 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.143881e-01 | 0.039 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.151867e-01 | 0.038 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.151867e-01 | 0.038 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.154649e-01 | 0.038 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.175059e-01 | 0.037 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.175059e-01 | 0.037 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.175059e-01 | 0.037 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.175059e-01 | 0.037 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.175059e-01 | 0.037 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.175059e-01 | 0.037 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.182596e-01 | 0.037 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.218334e-01 | 0.035 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.218334e-01 | 0.035 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.232441e-01 | 0.035 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.254303e-01 | 0.034 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.260986e-01 | 0.033 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.263566e-01 | 0.033 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.263566e-01 | 0.033 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.263566e-01 | 0.033 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.263566e-01 | 0.033 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.263566e-01 | 0.033 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.263566e-01 | 0.033 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.263566e-01 | 0.033 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.276578e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.324182e-01 | 0.030 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.342581e-01 | 0.030 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.342581e-01 | 0.030 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.342581e-01 | 0.030 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.349939e-01 | 0.029 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.356427e-01 | 0.029 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.358272e-01 | 0.029 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.377287e-01 | 0.028 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.386199e-01 | 0.028 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.398233e-01 | 0.027 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.405200e-01 | 0.027 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.407151e-01 | 0.027 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.407151e-01 | 0.027 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.407151e-01 | 0.027 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.407584e-01 | 0.027 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 9.407584e-01 | 0.027 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.407584e-01 | 0.027 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.407584e-01 | 0.027 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.413123e-01 | 0.026 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.413123e-01 | 0.026 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.413123e-01 | 0.026 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.413123e-01 | 0.026 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.413123e-01 | 0.026 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.413123e-01 | 0.026 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.447344e-01 | 0.025 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.447344e-01 | 0.025 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.460347e-01 | 0.024 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.460347e-01 | 0.024 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.460347e-01 | 0.024 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.460347e-01 | 0.024 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.476099e-01 | 0.023 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.476099e-01 | 0.023 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.476099e-01 | 0.023 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.476099e-01 | 0.023 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.487505e-01 | 0.023 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.489710e-01 | 0.023 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.508613e-01 | 0.022 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.520932e-01 | 0.021 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.532320e-01 | 0.021 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.532320e-01 | 0.021 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.532320e-01 | 0.021 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.532320e-01 | 0.021 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.532320e-01 | 0.021 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.552738e-01 | 0.020 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.552738e-01 | 0.020 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.552738e-01 | 0.020 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.577903e-01 | 0.019 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.582512e-01 | 0.019 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.582512e-01 | 0.019 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.582512e-01 | 0.019 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.582512e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.582512e-01 | 0.019 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.582512e-01 | 0.019 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.582512e-01 | 0.019 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.582512e-01 | 0.019 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.582512e-01 | 0.019 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.582512e-01 | 0.019 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.594827e-01 | 0.018 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.598042e-01 | 0.018 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.616839e-01 | 0.017 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.622753e-01 | 0.017 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.627319e-01 | 0.016 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.627319e-01 | 0.016 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.627319e-01 | 0.016 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.627319e-01 | 0.016 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.627319e-01 | 0.016 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.629873e-01 | 0.016 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.629873e-01 | 0.016 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.657916e-01 | 0.015 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.657916e-01 | 0.015 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.664749e-01 | 0.015 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.667320e-01 | 0.015 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.667320e-01 | 0.015 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.667320e-01 | 0.015 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.667320e-01 | 0.015 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.667320e-01 | 0.015 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.675042e-01 | 0.014 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.675042e-01 | 0.014 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.694137e-01 | 0.013 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.694137e-01 | 0.013 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.694137e-01 | 0.013 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.694137e-01 | 0.013 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.703029e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.703029e-01 | 0.013 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.703029e-01 | 0.013 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.703029e-01 | 0.013 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.734908e-01 | 0.012 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.734908e-01 | 0.012 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.734908e-01 | 0.012 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.734908e-01 | 0.012 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.734908e-01 | 0.012 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.736155e-01 | 0.012 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.736866e-01 | 0.012 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.747575e-01 | 0.011 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.763366e-01 | 0.010 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.763366e-01 | 0.010 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.763366e-01 | 0.010 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.763366e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.763366e-01 | 0.010 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.763366e-01 | 0.010 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.763366e-01 | 0.010 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.763366e-01 | 0.010 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.767468e-01 | 0.010 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.785694e-01 | 0.009 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.788770e-01 | 0.009 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.788770e-01 | 0.009 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.788770e-01 | 0.009 | 0 | 0 |
| Phosphate bond hydrolysis by NTPDase proteins | R-HSA-8850843 | 9.788770e-01 | 0.009 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.788770e-01 | 0.009 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.788770e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.791931e-01 | 0.009 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.811177e-01 | 0.008 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.811449e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.811449e-01 | 0.008 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.811449e-01 | 0.008 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.813148e-01 | 0.008 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.824889e-01 | 0.008 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.828690e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.828690e-01 | 0.008 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.828859e-01 | 0.007 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.831693e-01 | 0.007 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.831693e-01 | 0.007 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.834686e-01 | 0.007 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.834686e-01 | 0.007 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.839806e-01 | 0.007 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.844620e-01 | 0.007 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.844620e-01 | 0.007 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.844620e-01 | 0.007 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.844620e-01 | 0.007 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.849421e-01 | 0.007 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.849765e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.849765e-01 | 0.007 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.849765e-01 | 0.007 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.849765e-01 | 0.007 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.851035e-01 | 0.007 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.856571e-01 | 0.006 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.865898e-01 | 0.006 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.865898e-01 | 0.006 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.872274e-01 | 0.006 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.872274e-01 | 0.006 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.876848e-01 | 0.005 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.880299e-01 | 0.005 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.883091e-01 | 0.005 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.884239e-01 | 0.005 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.888625e-01 | 0.005 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.892061e-01 | 0.005 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.893155e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.893155e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.893155e-01 | 0.005 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.898569e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.898569e-01 | 0.004 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.904630e-01 | 0.004 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.904630e-01 | 0.004 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.904630e-01 | 0.004 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.904979e-01 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.904979e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.914873e-01 | 0.004 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.914873e-01 | 0.004 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.914873e-01 | 0.004 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.924017e-01 | 0.003 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.932179e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.932179e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.936182e-01 | 0.003 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.939465e-01 | 0.003 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.939465e-01 | 0.003 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.942217e-01 | 0.003 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.942217e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.942421e-01 | 0.003 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.945969e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.945969e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.945969e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.947720e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.950344e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.951774e-01 | 0.002 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.951774e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.956955e-01 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.956955e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.957229e-01 | 0.002 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.959645e-01 | 0.002 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.959807e-01 | 0.002 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.961581e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.961581e-01 | 0.002 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.961581e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.965033e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.965033e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.965709e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.966504e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.972632e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.972683e-01 | 0.001 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.972683e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.973573e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.974677e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.978932e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.980579e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.980971e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.982715e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.983135e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.986438e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.986910e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.987354e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.987354e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.987678e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.987678e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.987840e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.988586e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.988965e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.989700e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.990185e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.990701e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.991014e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.992183e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.992433e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.993023e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.993846e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.993846e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.993910e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994451e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.995041e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.995574e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.995574e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.996051e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.996855e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997229e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997432e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997895e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.998005e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998005e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.998005e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998220e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998414e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998533e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.998583e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998735e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998735e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.998735e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.998879e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998900e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.998950e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998954e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.998954e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998993e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999198e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999245e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.999356e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999462e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999476e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999500e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999636e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999659e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999712e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999874e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999884e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999892e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999909e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999932e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999942e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999947e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999948e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999948e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999959e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999989e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999990e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999992e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999993e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999996e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999998e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |